Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion type Assertion NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_head.
- NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion description "[The plasma concentrations of thrombin-activatable fibrinolysis inhibitor were significantly increased in lung cancer patients compared to healthy subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_provenance.
- NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion evidence source_evidence_literature NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_provenance.
- NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion SIO_000772 15224354 NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_provenance.
- NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion wasDerivedFrom befree-20140225 NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_provenance.
- NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_assertion wasGeneratedBy ECO_0000203 NP405700.RAFkZ1_QTMsnFo88CCeW779ruoBh50xOwewwlwGkw5kMY130_provenance.